Abstract
Metformin is a widely used drug in the therapy of patients affected by diabetes mellitus. Although some caution is needed in the very old, advanced age per se does not represent a contraindication to metformin use. Despite the fact that its precise mechanism of action it is not completely elucidated, long-term treatment with this drug in monotherapy, improves glycaemic control and reduces cardiovascular mortality in overweight type 2 diabetic patients. Experimental evidence produced over the years suggests that metformin may be useful in some clinical conditions different from diabetes mellitus. In the present review we have examined currently available data about the possible use of metformin as an effective therapeutical agent in pathological conditions different from type 2 diabetes mellitus. On the basis of our investigation, the use of metformin can be suggested in overweigth patients affected by impaired glucose tolerance and/or fasting hyperglycaemia and in subjects affected by polycystic ovary syndrome, while further data are needed in order to prescribe such a drug in patients affected by non-alcoholic steato-hepatitis and in HIV patients on antiretroviral therapy.
Keywords: HIV syndrome, Insulin resistance, Metformin, Non-alcoholic steatohepatitis, Obesity, Polycystic ovary syndrome, Pregnancy
Current Diabetes Reviews
Title: Metformin Beyond Diabetes: New Life for an Old Drug
Volume: 2 Issue: 3
Author(s): Carlo M. Rotella, Matteo Monami and Edoardo Mannucci
Affiliation:
Keywords: HIV syndrome, Insulin resistance, Metformin, Non-alcoholic steatohepatitis, Obesity, Polycystic ovary syndrome, Pregnancy
Abstract: Metformin is a widely used drug in the therapy of patients affected by diabetes mellitus. Although some caution is needed in the very old, advanced age per se does not represent a contraindication to metformin use. Despite the fact that its precise mechanism of action it is not completely elucidated, long-term treatment with this drug in monotherapy, improves glycaemic control and reduces cardiovascular mortality in overweight type 2 diabetic patients. Experimental evidence produced over the years suggests that metformin may be useful in some clinical conditions different from diabetes mellitus. In the present review we have examined currently available data about the possible use of metformin as an effective therapeutical agent in pathological conditions different from type 2 diabetes mellitus. On the basis of our investigation, the use of metformin can be suggested in overweigth patients affected by impaired glucose tolerance and/or fasting hyperglycaemia and in subjects affected by polycystic ovary syndrome, while further data are needed in order to prescribe such a drug in patients affected by non-alcoholic steato-hepatitis and in HIV patients on antiretroviral therapy.
Export Options
About this article
Cite this article as:
M. Rotella Carlo, Monami Matteo and Mannucci Edoardo, Metformin Beyond Diabetes: New Life for an Old Drug, Current Diabetes Reviews 2006; 2 (3) . https://dx.doi.org/10.2174/157339906777950651
DOI https://dx.doi.org/10.2174/157339906777950651 |
Print ISSN 1573-3998 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6417 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Cardiovascular Alterations After Spinal Cord Injury: An Overview
Current Medicinal Chemistry - Cardiovascular & Hematological Agents Ultra-Fast Acting Insulin Analogues
Recent Patents on Endocrine, Metabolic & Immune Drug Discovery Multiple Lipid-lowering Treatment in Pediatric Patients with Hyperlipidemia
Medicinal Chemistry Human Papilloma Virus Vaccine Associated Uveitis
Current Drug Safety Subject Index to Volume 4
Current Drug Targets - Immune, Endocrine & Metabolic Disorders Point-of-Care Testing in Diabetes Care
Mini-Reviews in Medicinal Chemistry A Systematic Review on Pharmaceutical Diabetic Care Services in the United Arab Emirates (UAE)
Current Diabetes Reviews Adenosine Myocardial Perfusion Imaging
Current Medical Imaging miR-126 as a Therapeutic Agent for Diabetes Mellitus
Current Pharmaceutical Design GLP-1 Agonists Exenatide and Liraglutide: A Review About Their Safety and Efficacy
Current Clinical Pharmacology Environmental (Lifestyle) Risk Factors for LADA
Current Diabetes Reviews Persistent Clinical Response of Infliximab Therapy in Patients with Refractory Rheumatoid Arthritis, over a 3-Year Period
Current Clinical Pharmacology The Adipose Tissue in Farm Animals: A Proteomic Approach
Current Protein & Peptide Science Cardiovascular Morbidity and Mortality in Peripheral Arterial Disease
Current Drug Targets - Cardiovascular & Hematological Disorders AMPK Regulation of Glucose, Lipid and Protein Metabolism: Mechanisms and Nutritional Significance
Current Protein & Peptide Science Monitoring and Surveillance of Obesity in the United States
Current Nutrition & Food Science Recent Efforts to Develop Imaging Methods and β -Cell-Specific Contrast Agents for Non-Invasive in vivo Assessment of β-Cell Mass
Recent Patents on Endocrine, Metabolic & Immune Drug Discovery Controlled and Continuous Release Ocular Drug Delivery Systems: Pros and Cons
Current Drug Delivery Analysis of Contrast-Enhanced Intravascular Ultrasound Images for the Assessment of Coronary Plaque Neoangiogenesis: Another Step Closer to the Identification of the Vulnerable Plaque
Current Pharmaceutical Design Role of Resistin in Insulin Sensitivity in Rodents and Humans
Current Protein & Peptide Science